Zynex received 1,912 orders during the month of July, 104% more than the 937 orders received in July of last year and 8% less than June orders.
Thomas Sandgaard, CEO commented: “We are currently receiving orders at a rate of more than twice of the level last year and have stabilized at that level, primarily due to our capital constraints. We have the potential to grow significantly more but are significantly limited in our ability to build new products for patient orders and field demo units. July and August are traditionally slow due to summer vacations and at this point we are estimating August orders to come in around 2,000. We are diligently seeking additional funding to take advantage of the huge electrotherapy market potential with very little competition.”
Zynex, founded in 1996, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company’s proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex is also developing a new blood volume monitor for use in hospitals and surgery centers. For additional information, please visit: Zynex.com.
Safe Harbor Statement
Statements made in this presentation include financial estimates and forward-looking statements that are not historical facts. Each of these estimates and forward-looking statements involves risk and uncertainties. These estimates are based on present circumstances, information currently available, and assumptions about future revenues, industry growth, and general economic conditions. Estimates are inherently uncertain as they are based on assumptions concerning future events. No representations can be made as to the accuracy of such information or the reliability of such assumptions. Accordingly, actual revenues and expenditures may vary significantly from the Company’s estimates, and actual results or developments may differ materially from those expressed or implied by the forward-looking statements. Factors that could cause actual results to differ from the financial estimates and forward-looking statements in this presentation include those described in the Company’ s filings with the Securities and Exchange Commission, including the Risk Factors section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2015. Therefore, neither the Company’s estimates nor the assumptions upon which they are based are to be interpreted as a guarantee or promise of the Company or management. The Company has no obligation to modify, amend, update, alter, or change the estimates contained herein.
To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/zynex-announces-july-orders-300313612.html
Copyright (C) 2016 PR Newswire. All rights reserved